<DOC>
	<DOCNO>NCT01855594</DOCNO>
	<brief_summary>To investigate efficacy lithium carbonate treatment neuropathic pain patient spinal cord injury .</brief_summary>
	<brief_title>Study Evaluate Efficacy Lithium Carbonate Spinal Cord Injury Patients With Neuropathic Pain</brief_title>
	<detailed_description>This randomize , placebo-controlled , double-blinded trial . Sixty spinal cord injure subject neuropathic pain randomize two group . The subject Treatment Group receive lithium carbonate tablet , Control Group receive placebo tablet . Neither subject physician know group subject allocate . Each subject receive 6 week oral lithium carbonate placebo . In Treatment Group , dose adjust accord serum lithium level . While Control Group , dose adjust base dummy serum level report . The outcome assess visit 1 week , 2 week , 6 week 12 week , phone call follow-up 24 week start medication . The primary outcome measure severity level pain . The efficacy safety analyze comparing result Treatment Group Control Group</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Age 18 65 ; Diagnosis traumatic spinal cord injury ; Clinically diagnose neuropathic pain ; Pain severity least 4 11point numeric rating scale screening ; Pain present regularly least 6 week enrollment ; Able understand instruction provide reliable pain assessment ; Subjects voluntarily sign dated Ethics Committee approve informed consent form ; Significant renal , cardiovascular , hepatic , infectious psychiatric disease ; Significant brain injury neurological deficit ; Debilitation dehydration ; Addison 's disease ; Recent ( within 1 week ) current use antidiuretic drug interacts lithium , tricyclic antidepressant , nonsteroidal antiinflammatory drug tetracycline ; A history substance alcohol abuse within past 1 year ; A need elective surgery involve preoperative postoperative analgesic anesthetic study period ; Current pregnant breast feeding , female childbearing potential willing use approve method birth control ; Participation drug study last three month ; History oral lithium intake reason ; criterion , opinion investigator , suggest subject would compliant study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>